Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 9/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.62 |
| ▸ | CA12 | O43570 | 2/20 | 0.62 |
| ▸ | CA2 | P00918 | 2/20 | 0.62 |
| ▸ | CA4 | P22748 | 2/20 | 0.62 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.62 |
| ▸ | CA1 | P00915 | 1/20 | 0.62 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.62 |
| ▸ | CA6 | P23280 | 1/20 | 0.62 |
| ▸ | CA7 | P43166 | 1/20 | 0.62 |
| ▸ | CA9 | Q16790 | 1/20 | 0.62 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.53 |
| ▸ | MAPT | P10636 | 4/20 | 0.53 |
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | NPC1 | O15118 | 2/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.53 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Salicylic Acid SCHEMBL11166419 | 0.80 | ALDH1A1 (0.95) | HPGDKDM4EALDH1A1SMN1; SMN2CA12 | |
| Salicylic Acid SCHEMBL3778828 | 0.80 | ALDH1A1 (0.95) | HPGDKDM4EALDH1A1SMN1; SMN2CA12 | |
| SCHEMBL2494549 | 0.78 | HPGD (0.57) | HPGDKDM4EALDH1A1SMN1; SMN2CA12 | |
| SCHEMBL8498035 | 0.77 | ALDH1A1 (0.58) | HPGDKDM4EALDH1A1SMN1; SMN2CA12 | |
| SCHEMBL3190837 | 0.77 | HPGD (0.56) | HPGDKDM4EALDH1A1SMN1; SMN2CA12 | |
| SCHEMBL30043535 | 0.77 | HPGD (0.56) | HPGDKDM4EALDH1A1SMN1; SMN2CA12 | |
| SCHEMBL61048 | 0.77 | HPGD (0.56) | HPGDKDM4EALDH1A1SMN1; SMN2CA12 | |
| Salicylic Acid SCHEMBL8433746 | 0.77 | ALDH1A1 (1.00) | HPGDKDM4EALDH1A1SMN1; SMN2CA12 | |
| Salicylic Acid SCHEMBL1967 | 0.77 | ALDH1A1 (1.00) | HPGDKDM4EALDH1A1SMN1; SMN2CA12 | |
| Salicylic Acid SCHEMBL1509155 | 0.77 | ALDH1A1 (1.00) | HPGDKDM4EALDH1A1SMN1; SMN2CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 203 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117295704-A | Fullerene phosphate polydigalloyl and method | 西纳普有限责任公司 | 2023-12-26 | — | — | CN | claimed |
| WO-2011085454-A1 | GP120 -BINDING BENZENE COMPOUNDS AND SACCHARIDE COMPOUNDS | KATHOLIEKE UNIVERSITEIT LEUVEN K.U.LEUVEN R&D (BE) | 2011-07-21 | — | — | WO | claimed |
| EP-1503778-B1 | FORMULATION OF A MIXTURE OF FREE-B-RING FLAVONOIDS AND FLAVANS AS A THERAPEUTIC AGENT | UNIGEN PHARMACEUTICALS INC (US) | 2009-08-05 | — | — | EP | claimed |
| US-20230148332-A1 | VACCINE ADJUVANTS | VIROVAX LLC | 2023-05-11 | — | — | US | disclosed |
| EP-4146204-A1 | VACCINE ADJUVANTS | Virovax LLC (US) | 2023-03-15 | — | — | EP | disclosed |
| US-20230024972-A1 | BAKUCHINOYL RETINOATE AND METHODS OF USE THEREOF | PHYTO TECH CORP D/B/A/ BLUE CALIFORNIA CO (US) | 2023-01-26 | — | — | US | disclosed |
| WO-2022266493-A1 | BAKUCHINOYL RETINOATE AND METHODS OF USE THEREOF | PHYTO TECH CORP D/B/A/ BLUE CALIFORNIA CO (US) | 2022-12-22 | — | — | WO | disclosed |
| US-11478411-B2 | Use of chelating agents for improving color stability of resorcinol | CONOPCO, INC. (US) | 2022-10-25 | — | — | US | disclosed |
| WO-2021226088-A1 | VACCINE ADJUVANTS | VIROVAX LLC (US) | 2021-11-11 | — | — | WO | disclosed |
| EP-2591082-B1 | COMPOSITIONS COMPRISING OPTICAL BENEFIT AGENTS | UNILEVER PLC (GB) | 2020-11-18 | — | — | EP | disclosed |
| EP-3558224-B1 | USE OF CHELATING AGENTS FOR IMPROVING COLOR STABILITY OF RESORCINOL | UNILEVER NV (NL) | 2020-04-29 | — | — | EP | disclosed |
| WO-2001001951-A1 | SHEET-LIKE DEVICES | THE PROCTER & GAMBLE COMPANY (US) | 2001-01-11 | — | — | WO | disclosed |
| US-6153208-A | A WATER INSOLUBLE SUBSTRATE HAVING A SEPARATE CLEANSING AND CONDITIONING PORTIONS WITH DIFFERENT WET EXTENSIBLE, A LATHERING SURFACTANT; DRY WASHCLOTH | THE PROCTER & GAMBLE COMPANY (US) | 2000-11-28 | — | — | US | disclosed |
| EP-1011630-A1 | CLEANSING AND CONDITIONING ARTICLE FOR SKIN OR HAIR | THE PROCTER & GAMBLE COMPANY (US) | 2000-06-28 | — | — | EP | disclosed |
| WO-1999055303-A1 | CLEANSING ARTICLES FOR SKIN AND/OR HAIR WHICH ALSO DEPOSITS SKIN CARE ACTIVES | THE PROCTER & GAMBLE COMPANY (US) | 1999-11-04 | — | — | WO | disclosed |
| WO-1999013861-A1 | CLEANSING AND CONDITIONING ARTICLE FOR SKIN OR HAIR | THE PROCTER & GAMBLE COMPANY (US) | 1999-03-25 | — | — | WO | disclosed |
| US-5149884-A | Oxidative dehydrogenation of aromatic or aliphatic alcohols in gas phase | BASF AKTIENGESELLSCHAFT (DE) | 1992-09-22 | — | — | US | disclosed |
| US-4600740-A | Hindered dydroxybenzyl hexaalkyldiphenyl-methanes and stabilized compositions | ICI AMERICAS INC. (US) | 1986-07-15 | — | — | US | disclosed |
| US-4224254-A | OXIDATION OF AROMATIC ALCOHOLS, SILVER CATALYST | BASF AKTIENGESELLSCHAFT (DE) | 1980-09-23 | — | — | US | disclosed |
| US-4200706-A | Curing of phenol-formaldehyde resins | CONOCO, INC. (US) | 1980-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230024972-A1 | BAKUCHINOYL RETINOATE AND METHODS OF USE THEREOF | RBP4, RARA, RARB | HPGD 224/4885KDM4E 791/4885ALDH1A1 227/4885 |
| US-20230148332-A1 | VACCINE ADJUVANTS | TLR7, TLR8, TLR1 | HPGD 3535/4885KDM4E 3968/4885ALDH1A1 4205/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.